Continuous biomanufacturing offers the potential for more agile, flexible production with improved robustness through the elimination of process steps, including hold steps, and the use of smaller ...

Scaling-up production of lentiviral vectors (LV)-based therapies is a persistent challenge for biomanufacturers, and one that threatens their development unless commercial-scale production ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...

Having assessed the responses to our survey of technology suppliers about expected automation purchasing and use trends in the discrete and batch manufacturing industries, we now turn our attention to ...